CAMP · NASDAQ
Camp4 Therapeutics (CAMP) Stock Price & Fundamentals
Camp4 Therapeutics (CAMP) closed at $628.37 on Oct 9, 2026, down 0.64% from the previous close of $632.42.
Share price, past year
1Y −7.85%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $628.37 |
| Sep 30, 2026 | $648.74 |
| Aug 31, 2026 | $614.61 |
| Jul 31, 2026 | $639.55 |
| Jun 30, 2026 | $660.21 |
| May 29, 2026 | $654.98 |
| Apr 30, 2026 | $615.16 |
| Mar 31, 2026 | $592.65 |
| Feb 27, 2026 | $593.68 |
| Jan 30, 2026 | $616.28 |
| Dec 31, 2025 | $631.82 |
| Nov 28, 2025 | $647.55 |
| Oct 31, 2025 | $669.15 |
Key statistics
- Market cap
- $32.63B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.31
- Revenue (TTM)
- $4.22M
- Net income (TTM)
- −$107.24M
- Shares outstanding
- 51.9M
- Dividend yield
- —
- 52-week range
- $579.08 – $681.89
Camp4 Therapeutics's market cap is $32.63B, based on a share price of $628.37 and 51.9M shares outstanding as of Jun 30, 2026.
Financials
Camp4 Therapeutics reported revenue of $3.50M for fiscal 2025, up 436.50% from fiscal 2024.
Camp4 Therapeutics reported a net loss of $80.40M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $3.50M | +436.5% | −$80.40M | −2,298.5% | −$2.65 | −$29.83M |
| FY2024ended Dec 31, 2024 | $652.00K | +86.3% | −$51.79M | −7,943.4% | −$11.04 | −$46.00M |
| FY2023ended Dec 31, 2023 | $350.00K | — | −$49.29M | −14,083.1% | −$124.80 | −$44.83M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.78M | −$33.53M | −$0.58 |
| Q1 FY2026ended Mar 31, 2026 | $1.29M | −$18.33M | −$0.32 |
| Q4 FY2025ended Dec 31, 2025 | $348.00K | −$40.28M | −$0.86 |
| Q3 FY2025ended Sep 30, 2025 | $795.00K | −$15.10M | −$0.55 |
| Q2 FY2025ended Jun 30, 2025 | $1.50M | −$12.59M | −$0.62 |
| Q1 FY2025ended Mar 31, 2025 | $858.00K | −$12.43M | −$0.62 |
| Q4 FY2024ended Dec 31, 2024 | $652.00K | −$13.28M | $65.72 |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$13.48M | −$24.19 |
Company profile
- Name
- Camp4 Therapeutics Corp
- Ticker
- CAMP
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 100 Talcott Avenue, Suite 201, Watertown, MA 02472
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001736730
Recent SEC filings
- Sep 28, 2026
- Aug 13, 2026
- Aug 13, 2026
- Aug 4, 2026
- Jul 27, 2026
- Jun 12, 2026
- May 14, 2026
- May 7, 2026
Frequently asked questions
What is Camp4 Therapeutics's stock price?
Camp4 Therapeutics (CAMP) closed at $628.37 on Oct 9, 2026, down 0.64% from the previous close of $632.42.
What is Camp4 Therapeutics's market cap?
Camp4 Therapeutics's market cap is $32.63B, based on a share price of $628.37 and 51.9M shares outstanding as of Jun 30, 2026.
How much revenue does Camp4 Therapeutics make?
Camp4 Therapeutics reported revenue of $3.50M for fiscal 2025, up 436.50% from fiscal 2024.
Does Camp4 Therapeutics pay a dividend?
Yes. Camp4 Therapeutics declared $0.00 per share in dividends for fiscal 2025.
Sources and methodology
Fundamentals come from Camp4 Therapeutics Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures